UK markets close in 4 hours 24 minutes

Avadel Pharmaceuticals plc (AVDL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
16.84+0.60 (+3.69%)
At close: 04:00PM EDT
16.84 0.00 (0.00%)
After hours: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close16.24
Open16.47
Bid16.79 x 100
Ask16.86 x 400
Day's range16.26 - 16.86
52-week range8.00 - 17.47
Volume355,651
Avg. volume1,297,378
Market cap1.525B
Beta (5Y monthly)1.55
PE ratio (TTM)N/A
EPS (TTM)-2.00
Earnings date04 Mar 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est22.90
  • Insider Monkey

    Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript

    Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript March 4, 2024 Avadel Pharmaceuticals plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to Avadel Pharmaceuticals Fourth Quarter and Full Year 2023 Earnings Call. At this time, […]

  • GlobeNewswire

    Avadel Pharmaceuticals to Present at Upcoming Investor Conferences

    DUBLIN, Ireland, March 05, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in the following upcoming investor conferences: Leerink Global Biopharma Conference: Fireside chat on Monday, March 11 at 3:20 p.m. ET.UBS Virtual CNS Day: Fireside chat on Monday, March 18 at 12:30 p.m. ET. A live webcast of these events, as well as an archived

  • GlobeNewswire

    Avadel Pharmaceuticals Issues Statement On Patent Litigation

    DUBLIN, Ireland, March 04, 2024 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), today issued a statement in response to a jury ruling from the United States District Court for the District of Delaware (“Court”) in a patent suit brought by Jazz Pharmaceuticals Inc. regarding LUMRYZ™. Avadel is pleased with the jury’s decision ruling in favor of Avadel with respect to one of the contested patents. As it relates to the jury’s decision against Avadel regarding the additional contested